Author： Greener M.
Publisher： Elsevier
ISSN： 1471-4914
Source： Trends in Molecular Medicine, Vol.7, Iss.2, 2001-02, pp. : 44-45
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
By Majer M. Popov K.M. Harris R.A. Bogardus C. Prochazka M.
Molecular Genetics and Metabolism, Vol. 65, Iss. 2, 1998-10 ,pp. :
Access to resources
Recommend
By Chang M. Wang R.J. Yangco D.T. Sharp G.C. Komatireddy G.R. Hoffman R.W.
Clinical Immunology, Vol. 89, Iss. 1, 1998-10 ,pp. :
By Liao Rongxia Xu Yanmei Chen Min Chen Xiewan Zhan Xiaoqing Sun Jianguo
Hematology, Vol. 18, Iss. 4, 2013-07 ,pp. :
Daclizumab: outcome of phase III trials and mechanism of action
By Vincenti F. Nashan B. Light S.
Transplantation Proceedings, Vol. 30, Iss. 5, 1998-08 ,pp. :